ABSTRACT Eleven patients who had received surgical treatment for bullous emphysema had regular assessment of lung function for a minimum of four years (mean 8-8, range 4-20 years). For each patient we estimated the annual rate of change in FEV1 and "relaxed" vital capacity (before and after bronchodilator aerosol) and in carbon monoxide transfer factor (TLCO), transfer coefficient (Kco), and arterial carbon dioxide and oxygen tensions (Paco, and Pao2).
After surgical treatment of bullous emphysema improvement in lung function has been found in several studies.'-' Beneficial effects on symptoms have also been reported,5-8 though such effects may be poorly correlated with objective changes in lung function.67 Improvement in both symptoms and lung function values may be maintained over a long period,26-8 though patients who have undergone lobectomy have been reported to fare less well.35 We have estimated the annual rate of change of lung function in a group of patients who received surgical treatment for bullous emphysema.
Methods
Eleven men who had undergone surgical treatment of bullous emphysema have been assessed regularly for a minimum of four years (mean 8-8, range 4-20 years) . Details are shown in table 1. All patients were or had been cigarette smokers. Five patients continued to smoke after their operation, while six abandoned the habit before or immediately after surgery and did not smoke thereafter. There was no significant age difference between smokers and ex-smokers.
Forced expiratory volume in one second (FEV,) and vital capacity (VC) before and after inhalation of 200 ,ug salbutamol from an aerosol, transfer factor (TLCO), transfer coefficient (Kco), and arterial oxygen and carbon dioxide tensions (Pao2 and Paco2) were measured at each visit as described previously.9 Eight patients had lung function assessment before and after surgery.
Results FEV,, VC, and Pao2 improved significantly after operation, whereas TLco and Kco remained unchanged (table 2). There was no significant difference between the smokers and ex-smokers with respect to postoperative lung function except for Paco2, which was significantly higher in the exsmokers (p < 0.025).
In the smokers all lung function values apart from Paco2 declined with time and the regression coefficients of all the indices except Paco2 against time were significantly different from zero. In the ex-smokers only the postbronchodilator FEV, and Long-term changes in lung function after surgical treatment of bullous emphysema In a recent study' the rate of decline of FEV, in postoperative patients was 82 ml a year, which is again a higher rate than was found in the present study. Few of the former group, however, continued to smoke, and five of the 11 patients had a bullectomy.
In a group of emphysematous patients not undergoing surgery9 the rate of decline in FEV, and FVC was 16 and 15 ml a year in ex-smokers and 53 ml for both in smokers. The decline in lung function was faster in patients with upper lobe emphysema than it was in those with generalised or lower lobe emphysema.10 Most patients in this study had had upper lobe bullae before surgery and, interestingly, in the non-operated patients with upper zone emphysema FEV, declined at a mean rate of 46 ml a year for ex-smokers and 86 ml a year for smokersthough the two groups were not strictly comparable.
Our study was concerned only with patients who survived for four years or more after operation. It is Hughes, MacArthur, Hutchison, Hugh-Jones clear that certain patients may live for many years after surgical treatment, even when their initial lung function was poor. Those who continue to smoke appear to deteriorate at a faster rate than those who stop smoking. In some patients the threat of operation or the procedure itself may provide sufficient stimulus for them to abandon the habit.
